Editorial Comment to Adrenal metastasis in nivolumab‐treated renal cell carcinoma: A unique entity as a sanctuary site

Editorial Comment to Adrenal metastasis in nivolumab‐treated renal cell carcinoma: A unique entity as a sanctuary site

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of urology 2022-06, Vol.29 (6), p.599-599
Hauptverfasser: Santo, Noriaki Lukas, Koshiro, Nishimoto
Format: Artikel
Sprache:eng
Schlagworte:
Antineoplastic Agents, Immunological - adverse effects
Carcinoma, Renal Cell - drug therapy
Carcinoma, Renal Cell - pathology
Humans
Kidney Neoplasms - drug therapy
Kidney Neoplasms - pathology
Metastases
Nivolumab - therapeutic use
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 599
container_issue 6
container_start_page 599
container_title International journal of urology
container_volume 29
creator Santo, Noriaki Lukas
Koshiro, Nishimoto
description
doi_str_mv 10.1111/iju.14868
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2646941481</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2646941481</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3338-b6978eae7940027c888eae381091254b3c87406a4257814252130394efcb66ce3</originalsourceid><addsrcrecordid>eNp1kc1KAzEUhYMoWqsLX0ACbnQxNX_NZNyV4k9FcKPrIZPeQsrMpCYZtTsfwWf0SUwddSEYwr0kfBzuuQehI0pGNJ1zu-xGVCipttCACsEyRgTbRgNS0CJTNGd7aD-EJSGUM6p20R4fc6koYwP0ejm30Xmrazx1TQNtxNHhydxDm74aiDqkawO2LW7ts6u7Rlcfb-_Rg44wxz1noE5Fe2Nb1-gLPMFda586wEnPxjXWAWscdGtip_0aBxvhAO0sdB3g8LsP0ePV5cP0Jru7v55NJ3eZ4ZyrrJJFrkBDXghCWG6U2ry4oskbG4uKG5ULIrVg41zRVBnlhBcCFqaS0gAfotNed-VdmijEsrFhM69uwXWhZFLIQqTt0YSe_EGXrvPJ34bKGZfjghSJOusp410IHhblytsm2SopKTdxlCmO8iuOxB5_K3ZVA_Nf8mf_CTjvgRdbw_p_pXJ2-9hLfgK3lpRO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2672365909</pqid></control><display><type>article</type><title>Editorial Comment to Adrenal metastasis in nivolumab‐treated renal cell carcinoma: A unique entity as a sanctuary site</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Santo, Noriaki Lukas ; Koshiro, Nishimoto</creator><creatorcontrib>Santo, Noriaki Lukas ; Koshiro, Nishimoto</creatorcontrib><identifier>ISSN: 0919-8172</identifier><identifier>ISSN: 1442-2042</identifier><identifier>EISSN: 1442-2042</identifier><identifier>DOI: 10.1111/iju.14868</identifier><identifier>PMID: 35368122</identifier><language>eng</language><publisher>Australia: Wiley Subscription Services, Inc</publisher><subject>Antineoplastic Agents, Immunological - adverse effects ; Carcinoma, Renal Cell - drug therapy ; Carcinoma, Renal Cell - pathology ; Humans ; Kidney Neoplasms - drug therapy ; Kidney Neoplasms - pathology ; Metastases ; Nivolumab - therapeutic use</subject><ispartof>International journal of urology, 2022-06, Vol.29 (6), p.599-599</ispartof><rights>2022 The Japanese Urological Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3338-b6978eae7940027c888eae381091254b3c87406a4257814252130394efcb66ce3</cites><orcidid>0000-0001-5108-824X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fiju.14868$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fiju.14868$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,778,782,1414,27911,27912,45561,45562</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35368122$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Santo, Noriaki Lukas</creatorcontrib><creatorcontrib>Koshiro, Nishimoto</creatorcontrib><title>Editorial Comment to Adrenal metastasis in nivolumab‐treated renal cell carcinoma: A unique entity as a sanctuary site</title><title>International journal of urology</title><addtitle>Int J Urol</addtitle><subject>Antineoplastic Agents, Immunological - adverse effects</subject><subject>Carcinoma, Renal Cell - drug therapy</subject><subject>Carcinoma, Renal Cell - pathology</subject><subject>Humans</subject><subject>Kidney Neoplasms - drug therapy</subject><subject>Kidney Neoplasms - pathology</subject><subject>Metastases</subject><subject>Nivolumab - therapeutic use</subject><issn>0919-8172</issn><issn>1442-2042</issn><issn>1442-2042</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1KAzEUhYMoWqsLX0ACbnQxNX_NZNyV4k9FcKPrIZPeQsrMpCYZtTsfwWf0SUwddSEYwr0kfBzuuQehI0pGNJ1zu-xGVCipttCACsEyRgTbRgNS0CJTNGd7aD-EJSGUM6p20R4fc6koYwP0ejm30Xmrazx1TQNtxNHhydxDm74aiDqkawO2LW7ts6u7Rlcfb-_Rg44wxz1noE5Fe2Nb1-gLPMFda586wEnPxjXWAWscdGtip_0aBxvhAO0sdB3g8LsP0ePV5cP0Jru7v55NJ3eZ4ZyrrJJFrkBDXghCWG6U2ry4oskbG4uKG5ULIrVg41zRVBnlhBcCFqaS0gAfotNed-VdmijEsrFhM69uwXWhZFLIQqTt0YSe_EGXrvPJ34bKGZfjghSJOusp410IHhblytsm2SopKTdxlCmO8iuOxB5_K3ZVA_Nf8mf_CTjvgRdbw_p_pXJ2-9hLfgK3lpRO</recordid><startdate>202206</startdate><enddate>202206</enddate><creator>Santo, Noriaki Lukas</creator><creator>Koshiro, Nishimoto</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5108-824X</orcidid></search><sort><creationdate>202206</creationdate><title>Editorial Comment to Adrenal metastasis in nivolumab‐treated renal cell carcinoma: A unique entity as a sanctuary site</title><author>Santo, Noriaki Lukas ; Koshiro, Nishimoto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3338-b6978eae7940027c888eae381091254b3c87406a4257814252130394efcb66ce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antineoplastic Agents, Immunological - adverse effects</topic><topic>Carcinoma, Renal Cell - drug therapy</topic><topic>Carcinoma, Renal Cell - pathology</topic><topic>Humans</topic><topic>Kidney Neoplasms - drug therapy</topic><topic>Kidney Neoplasms - pathology</topic><topic>Metastases</topic><topic>Nivolumab - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Santo, Noriaki Lukas</creatorcontrib><creatorcontrib>Koshiro, Nishimoto</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Santo, Noriaki Lukas</au><au>Koshiro, Nishimoto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Editorial Comment to Adrenal metastasis in nivolumab‐treated renal cell carcinoma: A unique entity as a sanctuary site</atitle><jtitle>International journal of urology</jtitle><addtitle>Int J Urol</addtitle><date>2022-06</date><risdate>2022</risdate><volume>29</volume><issue>6</issue><spage>599</spage><epage>599</epage><pages>599-599</pages><issn>0919-8172</issn><issn>1442-2042</issn><eissn>1442-2042</eissn><cop>Australia</cop><pub>Wiley Subscription Services, Inc</pub><pmid>35368122</pmid><doi>10.1111/iju.14868</doi><tpages>603</tpages><orcidid>https://orcid.org/0000-0001-5108-824X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0919-8172
ispartof International journal of urology, 2022-06, Vol.29 (6), p.599-599
issn 0919-8172
1442-2042
1442-2042
language eng
recordid cdi_proquest_miscellaneous_2646941481
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Antineoplastic Agents, Immunological - adverse effects
Carcinoma, Renal Cell - drug therapy
Carcinoma, Renal Cell - pathology
Humans
Kidney Neoplasms - drug therapy
Kidney Neoplasms - pathology
Metastases
Nivolumab - therapeutic use
title Editorial Comment to Adrenal metastasis in nivolumab‐treated renal cell carcinoma: A unique entity as a sanctuary site
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T00%3A00%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Editorial%20Comment%20to%20Adrenal%20metastasis%20in%20nivolumab%E2%80%90treated%20renal%20cell%20carcinoma:%20A%20unique%20entity%20as%20a%20sanctuary%20site&rft.jtitle=International%20journal%20of%20urology&rft.au=Santo,%20Noriaki%20Lukas&rft.date=2022-06&rft.volume=29&rft.issue=6&rft.spage=599&rft.epage=599&rft.pages=599-599&rft.issn=0919-8172&rft.eissn=1442-2042&rft_id=info:doi/10.1111/iju.14868&rft_dat=%3Cproquest_cross%3E2646941481%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2672365909&rft_id=info:pmid/35368122&rfr_iscdi=true